Confusion concerning multiple versions of the childhood myositis assessment scale

Arthritis Care and Research

Volumn 66, Issue 4, 2014, Pages 648-

  Huber, Adam M ^a   Lovell, Daniel J ^b   Pilkington, Clarissa A ^c   Rennebohm, Robert M ^d   Rider, Lisa G ^e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD DISEASE; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; HUMAN; JUVENILE DERMATOMYOSITIS; JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY; LETTER; MYOSITIS; PHYSICAL CAPACITY; PHYSICIAN; RATING SCALE;

CHILD; HUMANS; MYOSITIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84896916932     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22239     Document Type: Letter

References (6)

1. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 2213-9.
2. Miller FM, Rider LG, Chung Y, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathy. Rheumatology (Oxford) 2001; 40: 1262-73.
3. Ruperto N, Ravelli A, Murray K, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 1452-9.
4. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008; 59: 4-13.
5. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004; 50: 1595-603.
6. Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford) 2011; 50: 137-45.